DRG Market Assessment reports

Clarivate Epidemiology’s coverage of chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL / SLL) comprises epidemiological estimates of key patient populations in 45 countries…

Clarivate Epidemiology’s coverage of chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL / SLL) comprises epidemiological estimates of key patient populations in 45 countries…

Clarivate Epidemiology’s coverage of chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL / SLL) comprises epidemiological estimates of key patient populations in 45 countries…

Clarivate Epidemiology’s coverage of chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL / SLL) comprises epidemiological estimates of key patient populations in 45 countries worldwide…

Clarivate Epidemiology’s coverage of CLL / SLL comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the diagnosed incidence and diagnosed…

Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key CLL / SLLpatient populations, covering 171 countries and more than…

KEY BENEFITS AND USES Pinpoint current drug positioning and uptake in one snapshot to facilitate forecasting. Drill down into physicians’ treatment sequences and understand whom to position…

Hemophilia A is a monogenic X-linked recessive bleeding disorder caused by the deficiency of clotting factor VIII. Prophylaxis, the typical care for hemophilia A patients, is especially preferred…

The treatment of multiple myeloma is complex, often involving combinations of CD38-blocking monoclonal antibodies (MAbs), immunomodulatory drugs (IMiDs), proteasome inhibitors (PIs), chemotherapy,…

Clarivate Epidemiology’s coverage of beta thalassemia (BT) comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States, France,…

Clarivate Epidemiology’s coverage of myelofibrosis comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany,…

Clarivate Epidemiology’s coverage of Waldenstrom macroglobulinemia (WM) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United…